Td Asset Management Inc Alkermes Plc. Transaction History

Td Asset Management Inc

$114 Billion
Q3 2025

A detailed history of Td Asset Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Td Asset Management Inc holds 124,670 shares of ALKS stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,670

Previous 216,442 42.4%

Holding current value

$3.62 Million

Previous $6.19 Million 39.6%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$26.13 - $30.46 $2.4 Million - $2.8 Million	-91,772 Reduced 42.4%	124,670 $3.74 Million
Q2 2025 Jul 28, 2025	BUY	$26.59 - $32.65 $287,172 - $352,620	10,800 Added 5.25%	216,442 $6.19 Million
Q1 2025 May 07, 2025	SELL	$28.08 - $36.0 $451,751 - $579,168	-16,088 Reduced 7.26%	205,642 $6.79 Million
Q4 2024 Feb 11, 2025	SELL	$25.7 - $31.46 $4.69 Million - $5.74 Million	-182,500 Reduced 45.15%	221,730 $6.38 Million
Q3 2024 Nov 01, 2024	BUY	$23.01 - $28.55 $152,740 - $189,514	6,638 Added 1.67%	404,230 $11.3 Million

Q2 2024 Aug 02, 2024	BUY	$23.21 - $27.24 $1.13 Million - $1.32 Million	48,600 Added 13.93%	397,592 $9.58 Million
Q1 2024 May 08, 2024	BUY	$26.4 - $32.56 $7.52 Million - $9.27 Million	284,792 Added 443.6%	348,992 $9.45 Million
Q4 2023 Feb 12, 2024	BUY	$23.37 - $28.68 $191,634 - $235,176	8,200 Added 14.64%	64,200 $1.78 Million
Q3 2023 Oct 27, 2023	BUY	$27.17 - $31.97 $1.52 Million - $1.79 Million	56,000 New	56,000 $1.57 Million
Q2 2022 Aug 04, 2022	SELL	$26.4 - $30.54 $19 Million - $22 Million	-719,989 Reduced 67.2%	351,400 $10.5 Million
Q1 2022 May 10, 2022	SELL	$23.07 - $27.99 $2.28 Million - $2.77 Million	-99,000 Reduced 8.46%	1,071,389 $28.2 Million
Q4 2021 Feb 10, 2022	BUY	$21.47 - $32.08 $13.1 Million - $19.5 Million	608,300 Added 108.22%	1,170,389 $27.2 Million
Q3 2021 Nov 09, 2021	SELL	$23.37 - $32.13 $100,491 - $138,159	-4,300 Reduced 0.76%	562,089 $17.3 Million
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $41,316 - $55,330	2,200 Added 0.39%	566,389 $14.7 Million
Q1 2021 May 14, 2021	BUY	$18.21 - $23.2 $1.29 Million - $1.65 Million	71,000 Added 14.4%	564,189 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $7.59 Million - $10.9 Million	493,189 New	493,189 $9.84 Million

Others Institutions Holding ALKS

# of Institutions

401

Shares Held

176M

Call Options Held

901K

Put Options Held

400K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Alkermes Plc. Transaction History